News

Linaxin participates in the 2023 China (Linyi) Cultural Tourism and Health Industry Expo, bringing precision testing to millions of households

[2023-09-13 09:40:19]

The 2023 China (Linyi) Cultural Tourism and Health Industry Expo will be held at the Linyi International Convention and Exhibition Center from August 26th to 28th, 2023. This expo is centered on promoting people's health and aims to implement the "Healthy China Strategy". It aims to promote the integrated development of the cultural, tourism, and health industries, showcase the latest products and technologies, and further promote the high-quality development of the health industry.

图片Linaxin Biotech showcased its core products at the expo, including the home self inspection series Changle Xin ®、 Changweile ™、 You'an Xin ™, Colorectal Cancer Early Screening Series Li Changsheng ®、 Lichang Light ®, And the fourth generation solid-state nanopore gene detector Lsmart-SP1 ™。 These exhibits demonstrate the R&D strength of Linaxin Biotechnology in the field of early screening for high-risk cancers and the innovative capability of developing the fourth generation solid-state nanopore gene detector, attracting a large number of visitors' attention on site.

It is worth mentioning that Linaxin exhibited the fourth generation solid-state nanopore gene detector Lsmart-SP1 ™ Prototype, this detector is the first domestically developed solid-state nanopore gene detector that is about to be mass-produced.

65cd781c8626544e6bac4fff714c40eLsmart SP1 TM has a volume of only iPad size and can be used to mix specific reagents with 5 μ l of sample into a chip sample pool without amplification. The test results can be observed within 10-15 minutes. In addition to the popular third-generation biological nanopore sequencing applications internationally, the fourth generation solid-state nanopore technology has significant advantages in stability, flexible flux, adjustable pore size, and easy integration. It also has great potential in early cancer screening applications, with an accuracy of 99% in detecting DNA methylation. Solid state nanopore chips are the core key to realizing this technology. The production base of Linaxin Lsmart-SP1+Cell231 detection chip and reagent kit will be located in Linyi, Shandong.

During the exhibition, Jun Xinyang, member of the Standing Committee of Linyi Municipal Party Committee, Deputy Mayor, and Deputy Secretary of the Party Group of the Municipal Government, visited the booth to guide the work, and gained a detailed understanding of the company's products and technologies. He expressed appreciation for the achievements of Linaxin in the field of biotechnology.

图片

图片

Linaxin Biotechnology showcased its strong biotechnology and innovation capabilities at the 2023 China (Linyi) Cultural Tourism and Health Industry Expo, and the company's exhibits received widespread attention. In the future, Linaxin will continue to increase investment in biotechnology research and development, promote the deep integration of biotechnology and the health industry, establish a high-level team for domestic research and development, production, and medical testing, and practice the development concept of "bringing precision testing to thousands of households"!